• 

  Tidal Change: China Takes Alzheimer’s ‘Seaweed Drug’ Off the Market
• 

  Lithium for Alzheimer’s? A Hype-Free Explainer
• 

  European Regulators Flip on Alzheimer’s Drug Kisunla
• 

  Roche’s ‘Brainshuttle’ Alzheimer’s Drug Heads for Phase 3 Trials
• 

  4 Big Questions About New Alzheimer’s Anti-Amyloid Drugs, Answered
• 

  Using HIV Drugs to Fight Alzheimer’s
• 

  Can Stem Cell Therapy Treat Neurodegenerative Disease?
• 

  So Far, Australia Approves Only 1 of the 2 New Alzheimer’s ‘Mab’ Drugs
• 

  The First FDA-Approved Alzheimer’s Blood Test: What You Need to Know
• 

  This Shingles Vaccine Could Cut Your Dementia Risk By 1/5
• 

  Everything You Wanted to Know About ARIA
• 

  Precision Prevention: The Latest on Alzheimer’s Vaccines
• 

  Alzheimer’s Anti-Amyloids Haven’t Wowed—What If They Were Administered Years Earlier?
• 

  How Down Syndrome Research Is Helping Scientists Understand Alzheimer’s
• 

  EU Approves Leqembi: Regulators Flip from ‘No’ to ‘Yes’ on Alzheimer’s Drug

Previous234Next